Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

NICE to recommend three new treatments for hep C

October 16, 2015 Medical Communications AbbVie, BMS, Bristol-Myers Squibb, Exviera, Gilead, NICE, Viekirax, daklinza, harvoni, hepatitis C

NICE has recommended Bristol-Myers Squibb’s Daklinza, Gilead’s Harvoni and AbbVie’s Viekirax, with or without Exviera, as treatments for some adults …
News
david_tweedale_and_ian_robinson

Ashfield UK makes two new business development appointments for its growing team

October 16, 2015 Medical Communications Ashfield UK

Ashfield has appointed David Tweedale and Ian Robinson as Business Development Managers to the UK Commercial and Clinical business, located …
Appointment
david_mustalish

The Prime Medical Group expands senior team in New York City

October 16, 2015 Medical Communications

The Prime Medical Group is pleased to announce several key appointments to its New York office as the company continues …
Appointment
texting mobile

Health apps now more popular than ever in the UK

October 16, 2015 Medical Communications apps, digital pharma, health technology, technology

The use of health apps has considerably increased over the past years, according to a new survey that has found …
News
NHS sign

NICE requests more evidence on Duchenne muscular dystrophy therapy

October 16, 2015 Medical Communications, Sales and Marketing Duchenne Muscular Dystrophy, NICE, PCT Therapeutics, Translarna, ataluren

NICE has chosen not to recommend has PTC Therapeutics’ treatment Translarna for Duchenne muscular dystrophy (DMD), asking for further clarification …
News

The Prime Medical Group expands senior team in New York City

October 15, 2015 Medical Communications The Prime Medical Group

The Prime Medical Group is pleased to announce several key appointments to its New York office as the company continues …
News
Press release
Valeant logo

Valeant receives court writ over US drug pricing

October 15, 2015 Medical Communications, Sales and Marketing Drug pricing, Isuprel, Nitropress, US, Valeant, subpoena

Valeant Pharmaceuticals has disclosed that it has received two subpoenas in the US, demanding evidence concerning the pricing and distribution …
News
lars-rebien-soerensen

Novo chief executive ranked ‘world’s best’

October 14, 2015 Medical Communications, Sales and Marketing Harvard Business Review, Lars Rebien Sorensen, Novo Nordisk

Novo Nordisk chief executive Lars Rebien Sørensen has been named the best-performing in the world by the Harvard Business Review. …
Appointment
erik_j

Lisa Rae Schopf and Erik J. Spek bolster Vedanta Biosciences team

October 14, 2015 Medical Communications, Research and Development

Vedanta Biosciences, a PureTech Health company developing a new class of therapies designed to modulate the human microbiome, has announced …
Appointment

Merck rebrands as ‘science and technology’ company

October 14, 2015 Medical Communications, Research and Development, Sales and Marketing Merck, Merck Millipore, Merck Serono, rebrand, restructure

Merck Group has rebranded to “reflect its transformation into a science and technology company”, and restructured its business to create …
News
berg_niven_narain

Berg interview: artificial intelligence and big data join the war on disease

October 13, 2015 Medical Communications, Research and Development AI, Berg, Big Data, genomics

Boston-based biopharmaceutical company Berg recently announced it joined an industry collaboration with Genomics England, set up by UK Prime Minister …
Feature
guido_rasi

EMA appoints Guido Rasi as executive director

October 9, 2015 Medical Communications, Sales and Marketing EMA, Guido Rasi

The European Medicines Agency’s (EMA’s) Management Board has nominated Professor Guido Rasi as the Executive Director of the Agency. The …
Appointment
money_pills

Oncology groups and doctors fight for lower-priced cancer treatments

October 9, 2015 Medical Communications, Research and Development, Sales and Marketing

Oncology groups such as the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) are working …
News
sanofi_olivier_brandicourt

Sanofi looks to increase productivity in France by 25%

October 9, 2015 Manufacturing and Production, Medical Communications Sanofi

Sanofi is looking for a deal with unions in order to boost productivity by 20-25% at French plants over three …
News
astrazeneca_plaque

AstraZeneca’s Moventig now available through NHS

October 9, 2015 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, moventig

AstraZeneca has announced that Moventig (naloxegol) has been made available for adult patients with opioid-induced constipation (OIC) in England and …
News
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026